ABVX Stock Analysis: Buy, Sell, or Hold?

ABVX - Abivax SA American Depositary Shares

Pharmaceutical Preparations
$136.94
2.03 (1.50%) β–²
5d: -1.15%
30d: +41.83%
90d: +8.86%
BUY
MODERATE Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Earnings: Sep 21, 2026

Get Alerted When ABVX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ’‘ BUY OPPORTUNITY: ABVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: ABVX is currently trading at $136.94, which is considered extended relative to its 30-day fair value range of $95.08 to $135.45.

Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $131.86, while resistance sits at $147.98.

Market Sentiment: ABVX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $161.00 (+19.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $95.08 - $135.45
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 60.5%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($161.00)

Trading Range Analysis

30-Day Trading Range $95.08 - $135.45
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $131.86
Resistance Level $147.98
Current Trend Strong Uptrend
Technical data as of Jul 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) -41.33
Wall Street Target $161.00 (+19.3%)
Revenue Growth (YoY) 35.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 15, 2026 4:04 PM ET
Data refreshes hourly during market hours. Next update: 5:04 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ABVX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$413 57 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$822 64 BUY
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 58 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 54 HOLD
APLS
Apellis Pharmaceuticals …
BUY
22 analysts
$41 59 HOLD

More Analysis for ABVX

ABVX Technical Chart ABVX Price Prediction ABVX Earnings Date ABVX Investment Advisor ABVX Fair Price Analyzer ABVX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals